Literature DB >> 15857302

Estrogens as protectants of the neurovascular unit against ischemic stroke.

Shao-Hua Yang1, Ran Liu, Evelyn J Perez, Xiaofei Wang, James W Simpkins.   

Abstract

Estrogens are now recognized as potent neuroprotectants in a variety of in vitro and in vivo model for cerebral ischemia. These protective effects of estrogens are seen in neurons, astrocytes, microglia and vascular endothelial cells and result in a profound protection of the brain during stroke. Herein, we provide a thesis that indicates that the protective effects of estrogens during stroke may be a combined effect on multiple targets of the neurovascular unit (NVU) through a fundamental protective effect of estrogens on the subcellular organelle that defines the fate of cells during insults, the mitochondria. By protecting mitochondria during insult, estrogens are able to reduce or eliminate the signal for cellular necrosis or apoptosis and thereby protect the NVU from ischemia/reperfusion. In this context, estrogens may be unique in their ability to target the cellular site of initiation of damage during stroke and could be a central compound in a multi-drug approach to the prevention and treatment of brain damage from stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857302     DOI: 10.2174/1568007053544174

Source DB:  PubMed          Journal:  Curr Drug Targets CNS Neurol Disord        ISSN: 1568-007X


  20 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  Neuroprotective effects of high affinity Σ1 receptor selective compounds.

Authors:  Robert R Luedtke; Evelyn Perez; Shao-Hua Yang; Ran Liu; Suwanna Vangveravong; Zhude Tu; Robert H Mach; James W Simpkins
Journal:  Brain Res       Date:  2011-12-31       Impact factor: 3.252

Review 3.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  HO1 and Wnt expression is independently regulated in female mice brains following permanent ischemic brain injury.

Authors:  Jatin Tulsulkar; Alicia Ward; Zahoor A Shah
Journal:  Brain Res       Date:  2017-02-17       Impact factor: 3.252

5.  Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.

Authors:  Ran Liu; Qing Liu; Shaoqing He; James W Simpkins; Shao-Hua Yang
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

6.  Estrogen receptor beta as a mitochondrial vulnerability factor.

Authors:  Shao-Hua Yang; Saumyendra N Sarkar; Ran Liu; Evelyn J Perez; Xiaofei Wang; Yi Wen; Liang-Jun Yan; James W Simpkins
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

Review 7.  Window of opportunity: estrogen as a treatment for ischemic stroke.

Authors:  Ran Liu; Shao-Hua Yang
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

Review 8.  Neuroprotective effects of estrogens following ischemic stroke.

Authors:  Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

9.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

10.  Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling.

Authors:  Joshua W Gatson; David L Maass; James W Simpkins; Ahamed H Idris; Joseph P Minei; Jane G Wigginton
Journal:  J Neuroinflammation       Date:  2009-10-22       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.